UGenome AI is a US based biotech software company developing next-generation tools for genomic data interpretation. Co-founded by CEO Zachary S. Brooks, Chief Strategy Office Peter Bannister, and Chief Genomics Officer Dr. Jayden Lee, PharmD, EMBA, the company specializes in secondary and tertiary genomic analysis—transforming raw sequencing data into actionable, repeatable insights.
The company’s core platforms include:
- ProPEx – Converts whole genome or exome sequencing data into structured pharmacogenetic reports, enabling precision prescribing and targeted drug–gene analysis.
- Maxx – Builds individualized reference genomes to improve variant detection in RNA and DNA sequencing, with immediate application in oncology research.
- Seq4Life (in development) – A versatile analysis engine designed for both germline and somatic datasets, with capabilities to produce customizable variant reports and targeted panels.
Innovations in Genomic Analysis with UGenome AI
UGenome AI operates on a “sequence once, analyze often” philosophy, positioning itself to benefit from the growing demand for cost-effective, AI-assisted genomic interpretation. In addition to its research tools, the company delivers a personalized medication service in partnership with CLIA- and CAP-certified laboratories, bridging the gap between genomic data and clinical application.
Strategic partnerships with PlexusDX, The Beautiful Way, Lincoln Health, Auna, and Clinical Media are expanding UGenomeAI’s reach across precision medicine, pharmacogenomics, and rare disease research. By combining AI-driven analytics with scalable cloud infrastructure, UGenome AI is creating a pathway for widespread adoption of whole genome sequencing in both research and clinical practice.
With its product-first approach and emphasis on scalability, UGenome AI is well-positioned to support the next wave of genomic innovation—helping laboratories, health systems, and research organizations unlock the full potential of their sequencing investments.
For more great articles, go here.
